Stock listing
CMPX Stock Price, News, Filings & Events — Compass Therapeutics, Inc.
Selected listing: CMPX · NASDAQ · USD · US
This page tracks Compass Therapeutics, Inc.'s CMPX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CMPX:NASDAQ. CMPX:NASDAQ is the stock-level entry point for investors researching Compass Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Compass Therapeutics, Inc. (ticker: CMPX) is a public company operating in the American market, with a market capitalization of approximately $372.8 million. The company focuses on developing innovative therapies to address unmet medical needs. Compass Therapeutics is committed to advancing its research and development efforts in the biopharmaceutical sector.

- Ticker
- CMPX:NASDAQ
- Asset type
- Stock
- Market cap
- $360.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Compass Therapeutics, Inc. CMPX:NASDAQ stock context
This page tracks Compass Therapeutics, Inc.'s CMPX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CMPX:NASDAQ. CMPX:NASDAQ is the stock-level entry point for investors researching Compass Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Compass Therapeutics, Inc. (ticker: CMPX) is a public company operating in the American market, with a market capitalization of approximately $372.8 million. The company focuses on developing innovative therapies to address unmet medical needs. Compass Therapeutics is committed to advancing its research and development efforts in the biopharmaceutical sector.
Latest news from Compass Therapeutics, Inc.
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
August 6, 2026
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
July 17, 2026
Compass Therapeutics to Participate in Upcoming June Investor Events
May 28, 2026
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-C...
May 21, 2026
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update
May 5, 2026
Compass Therapeutics, Inc. earnings calls
Research Compass Therapeutics, Inc.
Compass Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for CMPX:NASDAQ.
Compass Therapeutics, Inc. company profile
View the public company page for Compass Therapeutics, Inc. on 6ix.
Compass Therapeutics, Inc. news
Read company news and market updates connected to Compass Therapeutics, Inc..
Compass Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Compass Therapeutics, Inc..